SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
The SCS market saw double-digit declines in Q120 as elective procedures fell off a cliff toward the end ...
As the international response to COVID-19 shifts to preparing for a potential second wave, the Medtech i...
COVID-19 halts the Trauma Market’s Q120 growth, leading to a -2.8% YoY decline globally. Q120 was tracki...
This week, our expert analysts have sifted through the noise to present some of the latest product devel...
In Q120, the US and EU AWC markets experienced modest gains, offset by ROW (China) hit early in the quar...
Spine’s solid start to Q120 was derailed in March by COVID-19, leading to a -10.6% YoY decline globally....
As states begin to loosen restrictions and we try and put COVID-19 in the rear view mirror, in the words...
The Extremities Market was on track to post a strong Q120 finish but due to COVID-19 the market pulled u...
We are pleased to announce that Joe Mish has joined the team at SmartTRAK as Director of Sales. Joe has ...
As the world begins to reopen from COVID-19, the wound care industry is making progress on new medical d...
Login